Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 6:22 pm Sale | 2025-09-30 | 13G | MacKenzie Realty Capital, Inc. MKZR | Armistice Capital, LLC | 724,000 3.990% | -876,000 (-54.75%) | Filing History |
| 2025-10-07 4:15 pm Purchase | 2025-09-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | MORGAN STANLEY MS | 116,406 0.700% | 116,406 (New Position) | Filing History |
| 2025-08-14 9:31 pm Purchase | 2025-06-30 | 13G | MacKenzie Realty Capital, Inc. MKZR | Armistice Capital, LLC | 1,600,000 8.920% | 1,600,000 (New Position) | Filing History |
| 2025-08-05 5:00 pm Sale | 2025-06-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Soleus Capital Master Fund, L.P. | 658,145 3.700% | -472,534 (-41.79%) | Filing History |
| 2025-05-15 3:46 pm Purchase | 2025-03-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Armistice Capital, LLC | 1,516,000 8.480% | 364,000 (+31.60%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | BlackRock Inc. BLK | 1,381,983 7.700% | -366,124 (-20.94%) | Filing History |
| 2025-02-14 5:18 pm Sale | 2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Armistice Capital, LLC | 1,152,000 6.540% | -384,000 (-25.00%) | Filing History |
| 2025-02-11 4:00 pm Purchase | 2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Soleus Capital Master Fund, L.P. | 1,130,679 6.400% | 195,891 (+20.96%) | Filing History |
| 2025-02-07 1:42 pm Sale | 2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Invesco Ltd. IVZ | 6,449 0.000% | -1,044,906 (-99.39%) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | BlackRock Inc. BLK | 1,748,107 9.900% | 1,748,107 (New Position) | Filing History |
| 2024-11-14 5:18 pm Purchase | 2024-09-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Armistice Capital, LLC | 1,536,000 8.730% | 1,536,000 (New Position) | Filing History |
| 2024-11-14 3:33 pm Purchase | 2024-09-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Soleus Capital Master Fund, L.P. | 934,788 5.300% | 934,788 (New Position) | Filing History |
| 2024-11-08 09:33 am Purchase | 2024-11-08 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Invesco Ltd. IVZ | 1,051,355 6.000% | 1,051,355 (New Position) | Filing History |
| 2024-02-14 2:30 pm Purchase | 2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Armistice Capital, LLC | 1,710,000 9.810% | 14,400 (+0.85%) | Filing History |
| 2024-02-13 5:13 pm Sale | 2023-12-29 | 13G | Rigel Pharmaceuticals, Inc. RIGL | VANGUARD GROUP INC | 895,322 5.130% | -313,058 (-25.91%) | Filing History |
| 2024-02-09 12:17 pm Purchase | 2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | MORGAN STANLEY MS | 1,449,060 8.300% | 1,449,060 (New Position) | Filing History |
| 2024-02-05 5:34 pm Sale | 2023-12-29 | 13G | Rigel Pharmaceuticals, Inc. RIGL | GOLDMAN SACHS GROUP INC GS | 25,568 0.100% | -911,439 (-97.27%) | Filing History |
| 2024-02-02 09:56 am Purchase | 2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Soleus Capital Master Fund, L.P. | 944,258 5.400% | 21,956 (+2.38%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | BlackRock Inc. BLK | 1,519,808 8.700% | 51,701 (+3.52%) | Filing History |
| 2023-06-12 08:21 am Sale | 2023-06-09 | 13G | Rigel Pharmaceuticals, Inc. RIGL | FMR LLC | 20,082 0.115% | -869,119 (-97.74%) | Filing History |